MIRM
Mirum Pharmaceuticals Inc
Price:  
53.01 
USD
Volume:  
379,718.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MIRM Relative Valuation

-140.4%
Upside

As of 2025-07-11, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (21.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 53.01 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -140.4%.

The range of the Relative Valuation is (16.30) - (29.54) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.9x - 18.9x 13.4x
Forward P/E multiples 10.4x - 21.6x 14.0x
Fair Price (16.30) - (29.54) (21.39)
Upside -130.8% - -155.7% -140.4%
53.01 USD
Stock Price
(21.39) USD
Fair Price

MIRM Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 -32.21
2025-07-02 -31.44
2025-07-01 -30.99
2025-06-30 -32.59
2025-06-27 -32.72
2025-06-26 -32.38
2025-06-25 -32.10
2025-06-24 -32.73
2025-06-23 -32.20
2025-06-20 -32.24
2025-06-18 -32.53
2025-06-17 -32.47
2025-06-16 -32.29
2025-06-13 -31.78
2025-06-12 -31.39
2025-06-11 -31.03
2025-06-10 -31.37
2025-06-09 -30.13
2025-06-06 -29.70
2025-06-05 -28.59
2025-06-04 -28.57
2025-06-03 -29.00
2025-06-02 -29.44
2025-05-30 -28.47
2025-05-29 -28.18
2025-05-28 -28.01
2025-05-27 -28.10
2025-05-23 -28.18
2025-05-22 -28.21
2025-05-21 -28.38
2025-05-20 -29.04
2025-05-19 -28.75
2025-05-16 -28.83
2025-05-15 -29.00
2025-05-14 -28.43
2025-05-13 -28.99
2025-05-12 -29.18
2025-05-09 -28.35
2025-05-08 -28.97
2025-05-07 -26.40
2025-05-06 -26.26
2025-05-05 -28.27
2025-05-02 -27.98
2025-05-01 -27.81
2025-04-30 -27.83
2025-04-29 -27.24
2025-04-28 -26.46
2025-04-25 -26.13
2025-04-24 -25.92
2025-04-23 -25.37